Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation
Cells · 2024
DOI: 10.3390/cells13211777 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Farah Ahmady und 9 weiteren Autor:innen. Beteiligte Einrichtung: Fiona Elsey Cancer Research Institute, Ballarat, VIC 3350, Australia. Hauptthemen laut MEDLINE: Glioblastoma, Hepatitis A Virus Cellular Receptor 2, Killer Cells, Natural. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inhibitory receptors are critical for regulating immune cell function. In cancer, these receptors are often over-expressed on the cell surface of T and NK cells, leading to reduced anti-tumor activity. Here, through the analysis of 11 commonly studied checkpoint and inhibitory receptors, we discern that only HAVCR2 (TIM3) and ENTPD1 (CD39) display significantly greater gene expression in glioblastoma compared to normal brain and lower grade glioma. Cell surface TIM-3, but not ENTPD1, was also elevated on activated CD4+ and CD8+ T cells, as well as on NK cells from glioblastoma patients compared to healthy donor T and NK cells. A subsequent analysis of molecules known to co-ordinate TIM-3 function and regulation was performed, which revealed that BAT3 expression was significantly reduced in CD4+ and CD8+ T cells, as well as NK cells from glioblastoma patients compared to counterparts from healthy donors. These pro-inhibitory changes are also correlated with reduced levels of the activation marker CD69 and the pro-inflammatory cytokine IFNγ in CD4+ and CD8+ T cells, as well as NK cells from glioblastoma patients. Collectively, these data reveal that glioblastoma-mediated CD4+ and CD8+ T cell and NK cell suppression is due, at least in part, to dysregulated TIM-3 and BAT3 expression and the associated downstream immunoregulatory and dysfunctional effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fiona Elsey Cancer Research Institute, Ballarat, VIC 3350, Australia.
- Federation University, Ballarat, VIC 3350, Australia.
- Townsville Hospital and Health Service, James Cook University, Townsville, QLD 4814, Australia.
- Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
- Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC 3050, Australia.
- Huagene Institute, Kecheng Science and Technology Park, Pukou District, Nanjing 211806, China.
ORCID-Profile: Peter Curpen, Louis Perriman, Siqi Wu, Rodney B Luwor
Zitieren
APA
Ahmady, F., Curpen, P., Perriman, L., Fonseca Teixeira, A., Wu, S., Zhu, H. J., Poddar, A., Jayachandran, A., Kannourakis, G., & Luwor, R. B. (2024). Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation. Cells. https://doi.org/10.3390/cells13211777
Vancouver
Ahmady F, Curpen P, Perriman L, Fonseca Teixeira A, Wu S, Zhu HJ, et al. Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation. Cells. 2024. doi:10.3390/cells13211777
BibTeX
@article{Ahmady2024,
author = {Ahmady, Farah and Curpen, Peter and Perriman, Louis and Fonseca Teixeira, Adilson and Wu, Siqi and Zhu, Hong-Jian and Poddar, Arpita and Jayachandran, Aparna and Kannourakis, George and Luwor, Rodney B},
title = {Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13211777}
}
EUVIMED